Dixon Technologies Faces FY27 Scrutiny After Weak Q4 Revenue Growth Why UBS Remains Bullish on Gold and Silver Despite PostPeak Pullback Arcutis Biotherapeutics CFO Latha Vairavan Offloads 9156 in Shares Chinese Investors With Few Options Turn to Dividends